Catalog No.
DHD72803
Expression system
Mammalian cells
Species reactivity
Human
Host species
Human
Isotype
IgG1-kappa
Target
ACVR2, ACTRIIA, ACTR-IIA, Activin receptor type IIA, ACVR2A, Activin receptor type-2A
Concentration
1.21 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P27037
Applications
Research Grade Biosimilar
Form
Liquid
Storage buffer
100 mM Pro-Ac, 20 mM Arg, pH 5.0
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
Laekna102
Genomic characterization of vulvar squamous cell carcinoma reveals differential gene expression based on clinical outcome., PMID:38086165
Colonic Adenocarcinomas Harboring NTRK Fusion Genes: A Clinicopathologic and Molecular Genetic Study of 16 Cases and Review of the Literature., PMID:31567189
Updated protocols for the detection of Sotatercept and Luspatercept in human serum., PMID:30203930
Detection of Sotatercept (ACE-011) in human serum by SAR-PAGE and western single blotting., PMID:29193906
Antibody-based strategies for the detection of Luspatercept (ACE-536) in human serum., PMID:28929587
MicroRNAs Involved in Asthma After Mesenchymal Stem Cells Treatment., PMID:27106170
Sotatercept, a soluble activin receptor type 2A IgG-Fc fusion protein for the treatment of anemia and bone loss., PMID:20886391
For research use only. Not for human or drug use.
